Reports

Ideas That Generate Results

US Generic Drug Market Outlook 2018

US Generic Drug Market Outlook 2018

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Feb, 2015| No. of Pages : 110

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1200.00
CD-ROM Mail Delivery
US$ 1400.00
Hard Copy Mail Delivery
US$ 1400.00
Electronic Access - Multi-User License
US$ 1800.00

List of Figures:

Figure 3-1: Personal Disposable Income (Billion US$), 2008-2013
Figure 3-2: Total Health Expenditure (Billion US$), 2008-2013
Figure 3-3: Share of Public & Private Health Expenditure (2008-2013)
Figure 3-4: Population above 65 Years (Million), 2008-2013
Figure 5-1: US Pharmaceutical Market (Billion US$), 2013-2018
Figure 5-2: US Pharmaceutical Supply Chain
Figure 5-3: Share of Branded and Generics Drugs by Revenue (2013)
Figure 5-4: Market Share by Total Prescriptions (2011-2013)
Figure 5-5: Generic Drugs Market (Billion US$), 2013-2018
Figure 6-1: Estimated Cancer Deaths (2012 & 2013)
Figure 6-2: Adult Obesity Rate (%), 2013 & 2030
Figure 6-3: Diabetic Patients in Age Group 20-79 Years ('000), 2013 & 2030
Figure 8-1: Generic Drugs Approval Process
Figure 9-1: Share of Key Players in Generics Market (2013)
Figure 9-2: Teva Pharmaceuticals - Generics Revenue Share by Geographic Regions (2014)
Figure 9-3: Actavis Plc - Revenue Share by Geographic Regions (2013)
Figure 9-4: Mylan Inc - Revenue Share by Geographic Regions (2013)
Figure 9-5: Mylan Inc - Generics Revenue Share by Geographic Region (2014)
Figure 9-6: Pfizer - Revenue Share by Business Segments (2013)
Figure 9-7: Pfizer - Revenue Share by Geographical Regions (2013)
Figure 9-8: Sandoz - Revenue Share by Business Segments (2014)
Figure 9-9: Novartis - Revenue Share by Geographic Regions (2014)
Figure 9-10: Endo International Plc - Revenue Share by Business Segments (2013)
Figure 9-11: Lupin Ltd - Revenue Share by Business Segments (2013)
Figure 9-12: Lupin Ltd - Generics Share in the US by Value (2012 & 2013)
Figure 9-13: Lupin Ltd - Revenue Share by Geographic Regions (2013)
Figure 9-14: Dr. Reddy’s Laboratory - Revenue Share by Business Segments (2013)
Figure 9-15: Dr. Reddy’s Laboratory - Revenue Share by Geographical Regions (2013)
Figure 9-16: Amneal Pharmaceuticals - Revenue (Million US$), 2007 & 2014

List of Tables:

Table 3-1: Total Health Expenditure (% of GDP), 2008-2013
Table 3-2: Blockbuster Drugs Going Off Patent (2014-2016)
Table 3-3: Premium Deals in the US Generics Industry (2013- 2015)
Table 6-1: Patent Expiration of Key Oncology Drugs
Table 6-2: Patent Expiration of Key Antipsychotic Drugs
Table 6-3: Patent Expiration of Key Antidepressant Drugs
Table 6-4: Prevalence of High Blood Pressure by Age & Gender (2013)
Table 6-5: Patent Expiration of Key Human Insulin Drugs
Table 6-6: Top 10 Proton Pump Inhibitors by Sales (Million US$), 2013
Table 6-7: Patent Expiration of Key Proton Pump Inhibitors
Table 6-8: Patent Expiry of Key Thyroid Drugs
Table 6-9: Patent Expiry of Key Respiratory Drugs
Table 7-1: Generic Drugs Launched in the US Market (2013 & 2014)
Table 7-2: List of Biosimilars under Development in the US
Table 9-1: Top Generic Drugs by Sales (Million US$), 2013
Table 9-2: Top Generic Drugs by Prescription (2013)
Table 9-3: Teva Pharmaceuticals - Revenue by Business Segments (Million US$), 2013 & 2014
Table 9-4: Teva Pharmaceuticals - Generics Revenue by Geographic Regions (Million US$), 2013 & 2014
Table 9-5: Actavis Plc - Revenue by Business Segments (Million US$), 2012 & 2013
Table 9-6: Mylan Inc - Revenue by Business Segments (Million US$), 2013 & 2014
Table 9-7: Pfizer - Revenue by Business Segments (Million US$), 2011-2013
Table 9-8: Endo International Inc - Revenue by Companies (Million US$), 2011-2013
Table 9-9: Lupin Ltd - Revenue by Business Segments (Million US$), 2011-2013
Table 9-10: Dr. Reddy's Laboratory - Revenue by Business Segments (Million US$), 2011-2013

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.